Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer - Peer2Peer

Sciam Account Sciam Acc

Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer

Aug 19, 2026

The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells

https://www.scientificamerican.com/article/moderna-and-merck-announce-landmark-trial-showing-mrna-therapy-significantly-cuts-odds-of-recurrent-skin-cancer/

Respond, make new discussions, see other discussions and customize your news...
Log in.

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Terms of Service